Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trialBruce E. Sands, Olga Fedorishina, Andrew Greenspan et al.|The Lancet|2022Cited by 295
Prevalence of Helicobacter pylori infection in the Vallès Occidental, CataloniaMarta Navarro, Ferrán Segura, Xavier Calvet et al.|Clinical Microbiology and Infection|1999Cited by 10
Cross-sectional study of human coding- and non-coding RNAs in progressive stages of Helicobacter pylori infectionSergio Lario, Xavier Calvet|Scientific Data|2020Cited by 3